• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盆腔包块患者算法的卵巢癌基础率。

Base rate of ovarian cancer on algorithms in patients with a pelvic mass.

机构信息

Gynecology and Obstetrics, Oslo University Hospital, Oslo, Norway.

National Advisory Center for Late Effects after Cancer Treatment, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.

出版信息

Int J Gynecol Cancer. 2020 Nov;30(11):1775-1779. doi: 10.1136/ijgc-2020-001416. Epub 2020 Jul 21.

DOI:10.1136/ijgc-2020-001416
PMID:32699016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7656145/
Abstract

OBJECTIVE

Algorithms have been developed to identify ovarian cancer in women with a pelvic mass. The aim of this study was to determine how the base rates of ovarian cancer influence the case finding abilities of recently developed algorithms applicable to pelvic tumors. We used three ovarian cancer algorithms and the principle of Bayes' theorem for risk estimation.

METHODS

First, we evaluated the case finding abilities of the Risk of Malignancy Algorithm, the Rajavithi-Ovarian Predictive Score, and the Copenhagen Index in a prospectively collected sample at Oslo University Hospital of 227 postmenopausal women with a 74% base rate of ovarian cancer. Second, we examined the case finding abilities of the Risk of Malignancy Algorithm in three published studies with different base rates of ovarian cancer. We applied Bayes' theorem in these examinations.

RESULTS

In the Oslo sample, all three algorithms functioned poorly as case finders for ovarian cancer. When the base rate changed from 8.2% to 43.8% in the three studies using the Risk of Malignancy Algorithm, the proportion of false negative ovarian cancer diagnoses increased from 1.2% to 3.4%, and the number of false positive diagnosis increased from 4.6% to 14.2%.

CONCLUSION

This study demonstrated that the base rate of ovarian cancer in the samples tested was important for the case finding abilities of algorithms.

摘要

目的

已经开发出算法来识别盆腔肿块女性中的卵巢癌。本研究的目的是确定卵巢癌的基础发生率如何影响适用于盆腔肿瘤的最近开发的算法的病例发现能力。我们使用了三种卵巢癌算法和贝叶斯定理的风险估计原理。

方法

首先,我们在奥斯陆大学医院前瞻性收集的 227 例绝经后妇女(卵巢癌的基础发生率为 74%)中评估了恶性肿瘤风险算法、Rajavithi-卵巢预测评分和哥本哈根指数的病例发现能力。其次,我们在三个具有不同卵巢癌基础发生率的已发表研究中检查了恶性肿瘤风险算法的病例发现能力。我们在这些检查中应用了贝叶斯定理。

结果

在奥斯陆样本中,所有三种算法在卵巢癌病例发现方面表现不佳。当使用恶性肿瘤风险算法的三项研究中的基础发生率从 8.2%变为 43.8%时,卵巢癌假阴性诊断的比例从 1.2%增加到 3.4%,假阳性诊断的数量从 4.6%增加到 14.2%。

结论

本研究表明,所测试样本中卵巢癌的基础发生率对算法的病例发现能力很重要。

相似文献

1
Base rate of ovarian cancer on algorithms in patients with a pelvic mass.盆腔包块患者算法的卵巢癌基础率。
Int J Gynecol Cancer. 2020 Nov;30(11):1775-1779. doi: 10.1136/ijgc-2020-001416. Epub 2020 Jul 21.
2
Low serum T3 levels are associated with false-positive results when using the risk of ovarian malignancy algorithm (ROMA) in women with benign ovarian disease.血清 T3 水平降低与良性卵巢疾病女性使用卵巢恶性肿瘤风险算法(ROMA)时出现假阳性结果有关。
Taiwan J Obstet Gynecol. 2021 Jan;60(1):36-40. doi: 10.1016/j.tjog.2020.10.006.
3
Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.评估 HE4、CA125、卵巢恶性肿瘤风险算法(ROMA)和恶性肿瘤指数(RMI)在盆腔肿块患者中作为上皮性卵巢癌的诊断工具。
Gynecol Oncol. 2012 Nov;127(2):379-83. doi: 10.1016/j.ygyno.2012.07.106. Epub 2012 Jul 24.
4
Clinical Performance Comparison of Two In-Vitro Diagnostic Multivariate Index Assays (IVDMIAs) for Presurgical Assessment for Ovarian Cancer Risk.两种用于卵巢癌风险术前评估的体外诊断多变量指数检测(IVDMIAs)的临床性能比较。
Adv Ther. 2019 Sep;36(9):2402-2413. doi: 10.1007/s12325-019-01010-8. Epub 2019 Jul 5.
5
[Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].[肿瘤标志物、评分(临床和生物学)算法在疑似上皮性卵巢癌的卵巢肿块诊断及预后评估中的价值:本文依据由FRANCOGYN、CNGOF、SFOG、GINECO - ARCAGY在CNGOF的支持下制定并经法国国家癌症研究所(INCa)认可的法国肿瘤学指南“上皮性卵巢癌患者的初始管理”起草]
Gynecol Obstet Fertil Senol. 2019 Feb;47(2):134-154. doi: 10.1016/j.gofs.2018.12.013. Epub 2019 Feb 5.
6
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.上皮性卵巢癌患者卵巢恶性肿瘤风险的诊断措施比较:一项荟萃分析。
Sci Rep. 2021 Aug 27;11(1):17308. doi: 10.1038/s41598-021-96552-9.
7
HE4, CA125, the Risk of Malignancy Algorithm and the Risk of Malignancy Index and complex pelvic masses - a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population.人附睾蛋白4、癌抗原125、恶性风险算法和恶性风险指数与复杂盆腔肿块——澳大利亚人群盆腔肿块术前评估中的前瞻性比较
Aust N Z J Obstet Gynaecol. 2015 Oct;55(5):493-7. doi: 10.1111/ajo.12363. Epub 2015 Jul 14.
8
A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index.一项验证 HE4、CA125、卵巢恶性肿瘤风险算法和恶性肿瘤风险指数性能的多中心临床试验。
Gynecol Oncol. 2018 Oct;151(1):159-165. doi: 10.1016/j.ygyno.2018.08.025. Epub 2018 Aug 24.
9
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.评估盆腔包块患者中卵巢恶性肿瘤风险算法的诊断准确性。
Obstet Gynecol. 2011 Aug;118(2 Pt 1):280-288. doi: 10.1097/AOG.0b013e318224fce2.
10
Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers.基于血液生物标志物的人工智能在卵巢上皮性癌术前诊断和预后预测中的应用。
Clin Cancer Res. 2019 May 15;25(10):3006-3015. doi: 10.1158/1078-0432.CCR-18-3378. Epub 2019 Apr 11.

引用本文的文献

1
Performance of the IOTA ADNEX model combined with HE4 for identifying early-stage ovarian cancer.IOTA ADNEX模型联合HE4用于识别早期卵巢癌的性能。
Front Oncol. 2022 Sep 16;12:949766. doi: 10.3389/fonc.2022.949766. eCollection 2022.
2
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study.基于生物标志物的附件包块术前评估模型:一项多中心验证研究
Cancers (Basel). 2022 Mar 31;14(7):1780. doi: 10.3390/cancers14071780.

本文引用的文献

1
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review.用于卵巢癌诊断的生物标志物和算法:CA125、HE4、RMI 和 ROMA,综述。
J Ovarian Res. 2019 Mar 27;12(1):28. doi: 10.1186/s13048-019-0503-7.
2
Rajavithi-ovarian cancer predictive score (R-OPS): A new scoring system for predicting ovarian malignancy in women presenting with a pelvic mass.拉贾维蒂卵巢癌预测评分(R-OPS):一种用于预测盆腔肿块女性卵巢恶性肿瘤的新评分系统。
Gynecol Oncol. 2016 Jun;141(3):479-484. doi: 10.1016/j.ygyno.2016.03.019. Epub 2016 Mar 22.
3
[A clinician and a bayesian].[一位临床医生和一位贝叶斯派学者]
Tidsskr Nor Laegeforen. 2015 Sep 8;135(16):1468-70. doi: 10.4045/tidsskr.15.0557.
4
A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.一种结合人附睾蛋白4(HE4)、癌抗原125(CA125)和年龄的新型诊断指标可能改善疑似卵巢癌女性的分诊——一项针对有卵巢肿物女性的国际多中心研究。
Gynecol Oncol. 2015 Sep;138(3):640-6. doi: 10.1016/j.ygyno.2015.06.021. Epub 2015 Jun 16.
5
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.浆液性卵巢交界性肿瘤(BOT)的手术分期与预后:AGO ROBOT研究的亚分析
Br J Cancer. 2015 Feb 17;112(4):660-6. doi: 10.1038/bjc.2014.648. Epub 2015 Jan 6.
6
Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer.结合临床评估和卵巢恶性肿瘤风险算法预测卵巢癌。
Gynecol Oncol. 2014 Dec;135(3):547-51. doi: 10.1016/j.ygyno.2014.10.017. Epub 2014 Oct 23.
7
HE4 and ROMA index in Czech postmenopausal women.捷克绝经后女性的 HE4 和 ROMA 指数。
Anticancer Res. 2012 Sep;32(9):4137-40.
8
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.一种利用人附睾蛋白4(HE4)和癌抗原125(CA125)预测盆腔肿块患者卵巢癌的新型多标志物生物测定法。
Gynecol Oncol. 2009 Jan;112(1):40-6. doi: 10.1016/j.ygyno.2008.08.031. Epub 2008 Oct 12.
9
Why clinicians are natural bayesians.临床医生为何是天生的贝叶斯派。
BMJ. 2005 May 7;330(7499):1080-3. doi: 10.1136/bmj.330.7499.1080.
10
Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses.基于血清CA125、超声检查结果及绝经状态的恶性肿瘤风险指数在盆腔肿块术前诊断中的评估
Br J Obstet Gynaecol. 1996 Aug;103(8):826-31. doi: 10.1111/j.1471-0528.1996.tb09882.x.